China Medicine Corporation (CHME)

0.0001 0.0000 (0.00%) At close: 10:30AM EDT

China Medicine Corporation

2/F, Guangri Tower
No.9 Siyounan Road 1st Street Yuexiu District
Guangzhou 510006
China
86 20 8739 1718
https://www.cmc621.com/cmc/index.php

Sector(s): Healthcare
Industry: Medical Distribution
Full-time employees: 281

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Senshan Yang	Chairman, CEO & Chairman of Guangzhou Konzern Medicine Co., Ltd	289.59k	N/A	1961
Mr. Ho Chi Fung	Chief Financial Officer	N/A	N/A	1972
Ms. Huizhen Yu	Controller	6.68k	N/A	1980

Amounts are as of 31 December 2009, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Corporate governance

China Medicine Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.